Conferences Acepodia is attending in 2026

Conference	Details	Involvement	Tnuki guide
38th EORTC-NCI-AACR Symposium on Molecular Targets and Cancer TherapeuticsCancer drug discovery & early-development scientistsOfficial site ↗	Nov 18–20, 2026 Barcelona, Spain ~1.5k attendees	On the programNo booth or sponsorship in the organizer’s published lists Program 1 poster PosterPhase 1 Multicenter Study of ACE1831, an Allogeneic Anti-CD20 Antibody-Conjugated Gamma Delta T-Cell Therapy, in Adult Subjects with Relapsed/Refractory CD20-Expressing B-Cell MalignanciesThu Nov 19 Attending presenter	Open the guide →Search and filter attendees
17th World ADC San DiegoAntibody-drug conjugate developersOfficial site ↗	Oct 12–15, 2026 Past San Diego, CA ~1.3k attendees	◇Program PartnerAs published by World ADC San Diego Program 1 talk TalkAntibody-Dual-Drug Conjugation (AD2C): Spotlighting an Engineering-Free Platform to Overcome Payload Resistance & Tumor Heterogeneity With Plug & Play Upgrade of Existing ADCsWed Oct 14 Attending Founder & Chief Executive Officer	Open the guide →Search and filter attendees

We hold published exhibitor, sponsor, program or attendee lists for 54 of the 156 conferences on our calendar, so this page shows Acepodia’s involvement at those 54 only — it is not a complete record of where they go. Organizers typically publish a list around six months before the event, so coverage grows over time.